Coversin in PNH in Patients With Resistance to Eculizumab Due to Complement C5 Polymorphisms
Clinical trial NCT03427060 · COMPLETED
Trial details
- NCT number
- NCT03427060
- Sponsor
- AKARI Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-14
- Primary completion
- 2018-11-15
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.